About
Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limited was founded in 2014 and is headquartered in Vadodara, India.
Key Metrics
as of Sep 2026Market Cap1,361 Cr
P/E86.00
Div Yield0.00 %
Book Value₹32.00
52w High₹175.00
52w Low₹98.20
Face Value₹2.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 9.24 | 9.24 | 9.76 | 9.64 | 11.45 | 8.02 | 8.51 | 9.41 |
| Expenses | 6.25 | 7.66 | 5.62 | 5.55 | 5.12 | 5.71 | 4.70 | 4.55 |
| Operating Profit | 2.99 | 1.58 | 4.14 | 4.09 | 6.33 | 2.31 | 3.81 | 4.86 |
| OPM % | 32.36 | 17.10 | 42.42 | 42.43 | 55.28 | 28.80 | 44.77 | 51.65 |
| Other Income | 0.65 | 0.45 | 0.03 | 0.02 | 0.00 | 0.04 | 0.02 | 0.04 |
| Depreciation | 0.64 | 0.67 | 0.72 | 0.75 | 0.80 | 0.75 | 0.66 | 0.74 |
| Interest | 0.35 | 0.50 | 0.29 | 0.23 | 0.13 | 0.12 | 0.11 | 0.16 |
| Profit before tax | 2.65 | 0.86 | 3.16 | 3.13 | 5.40 | 1.48 | 3.06 | 4.00 |
| Tax % | 23.02 | -59.30 | 26.27 | 26.20 | 27.78 | 14.19 | 27.78 | 26.25 |
| Net Profit | 2.04 | 1.37 | 2.33 | 2.30 | 3.90 | 1.26 | 2.21 | 2.96 |
| EPS in Rs | 0.26 | 0.17 | 0.30 | 0.40 | 0.69 | 0.22 | 13.73 | 18.39 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Sales | 40.10 | 35.17 | 4.77 | 0.00 |
| Expenses | 23.95 | 19.73 | 3.20 | 0.01 |
| Operating Profit | 16.15 | 15.44 | 1.57 | -0.01 |
| OPM % | 40.27 | 43.90 | 32.91 | — |
| Other Income | 0.49 | 0.11 | 0.70 | 0.00 |
| Interest | 1.15 | 0.53 | 0.04 | 0.00 |
| Depreciation | 2.94 | 2.93 | 0.28 | 0.00 |
| Profit before tax | 12.55 | 12.09 | 1.95 | -0.01 |
| Tax % | 21.12 | 24.73 | 25.13 | 0.00 |
| Net Profit | 9.90 | 9.11 | 1.45 | -0.01 |
| EPS in Rs | 1.26 | 1.60 | 72.50 | -0.50 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Equity Capital | 15.77 | 11.37 | 0.20 | 0.20 |
| Reserves | 230.69 | 14.05 | 10.69 | 0.17 |
| Borrowings | 16.08 | 5.48 | 1.94 | 0.00 |
| Other Liabilities | 3.54 | 18.17 | 3.99 | 3.50 |
| Total Liabilities | 266.08 | 49.07 | 16.82 | 3.87 |
| Fixed Assets | 25.71 | 28.42 | 9.74 | 2.67 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 108.58 | 1.51 | 0.00 | 0.01 |
| Other Assets | 131.79 | 19.14 | 7.08 | 1.19 |
| Total Assets | 266.08 | 49.07 | 16.82 | 3.87 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Cash from Operating Activity | -7.46 | 15.36 | -2.11 | 0.00 |
| Cash from Investing Activity | -213.76 | -19.43 | -7.35 | 0.00 |
| Cash from Financing Activity | 226.94 | 4.80 | 10.63 | 0.00 |
| Net Cash Flow | 5.72 | 0.73 | 1.17 | 0.00 |
| Free Cash Flow | -7.68 | -2.62 | -9.46 | 0.00 |
| CFO/OP % | -22.00 | 115.00 | -100.00 | 0.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Debtor Days | 171.85 | 132.84 | 318.32 |
| Inventory Days | 65.73 | 66.36 | 317.90 |
| Days Payable | 95.12 | 211.78 | 2,825.81 |
| Cash Conversion Cycle | 142.46 | -12.57 | -2,189.58 |
| Working Capital Days | 54.07 | -26.88 | 114.01 |
| ROCE % | 9.34 | 57.72 | 19.55 |
Corporate Actions
No corporate actions recorded.